Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
8%
ALSO IN OZEM
OZEM
21
HOLDINGS
26%
ALSO IN XLV
SECTOR DRIFT (XLV minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.4% | 16.3% | 12.4% |
|
AMGEN INC | 3.0% | 3.6% | 3.0% |
|
PFIZER INC | 2.7% | 3.8% | 2.7% |
|
GILEAD SCIENCES INC | 2.8% | 1.9% | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.1% | 2.8% | 1.1% |
XLV Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 8.6% |
|
ABBVIE INC | 7.6% |
|
UNITEDHEALTH GROUP INC | 6.2% |
|
ABBOTT LABORATORIES | 4.2% |
|
MERCK & CO. INC. | 4.1% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
INTUITIVE SURGICAL INC | 3.7% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
DANAHER CORP | 2.7% |
|
STRYKER CORP | 2.5% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.4% |
|
VIKING THERAPEUTICS, INC. | -5.9% |
|
ZEALAND PHARMA A/S | -5.3% |
 |
ROCHE HOLDING LTD | -5.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ELI LILLY & CO | -3.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.7% |
 |
INNOVENT BIOLOGICS, INC. | -3.5% |
|
TERNS PHARMACEUTICALS, INC. | -2.7% |
 |
HANMI PHARM CO LTD | -2.7% |